Samuel L. Aitken, PharmD, MPH, BCIDP*

home / authors / samuel-l-aitken-pharmd-mph-bcidp

Articles

Updates to Multidrug Resistance Guidance

February 23rd 2022

The 2019 Strategic Plan of the Infectious Diseases Society of America lays the groundwork for understanding prescribing practices.

Evaluating the Role of New Beta-Lactam Agents for Uncommon Pathogens

October 14th 2019

Novel β-lactam/β-lactamase inhibitor combinations and cefiderocol may play a part in the treatment of infections caused by Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Burkholderia cepacia complex.

About Us

Advertise

Editorial

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777